Sage Journals: Discover world-class research

Abstract

Background:

The impact of teleneurology on healthcare utilization (HCU) in MS is unknown.

Objective:

Evaluate the association between teleneurology and HCU.

Methods:

A retrospective longitudinal analysis of HCU among adult MS and clinically isolated syndrome (CIS) patients residing in the Cleveland/Akron area from July 2020 to July 2022. Negative binomial regression models evaluated the association between number of laboratory and MRI orders per visit and number of emergency visits per patient across patient groups with variable proportions of teleneurology visits.

Results:

A total of 3208 patients completed 15,795 visits. Patients using teleneurology had more visits (rate ratio (RR) 1.707–1.719, p < 0.001). Teleneurology visits had fewer laboratory (RR 0.571) and MRI orders (RR 0.693, p < 0.001). There was no difference in emergency care utilization for teleneurology patients (p ⩾ 0.05). More emergency visits were observed in Black (RR 1.414) and Medicaid (RR 1.893) patients, regardless of visit type (p < 0.001).

Conclusion:

Teleneurology visits were associated with fewer orders, suggesting teleneurology may be incorporated into healthcare models without increasing utilization related to the visit. Teleneurology was also associated with increased visit volumes but no difference in emergency HCU. More studies are needed to clarify the ultimate impact of teleneurology on overall HCU. More emergency visits, regardless of visit type, were observed among at-risk populations, warranting further investigation.

Keywords

Teleneurology health disparities telehealth healthcare utilization multiple sclerosis healthcare cost

Get full access to this article

View all access options for this article.

References

Feigin

Abajobir

Abate

, et al. Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017; 16: 877–897.

Wallin

Culpepper

Campbell

, et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology 2019; 92: e1029–e1040.

Bebo

Cintina

LaRocca

, et al. The economic burden of multiple sclerosis in the United States. Neurology 2022; 98: e1810–e1817.

Asche

Singer

Jhaveri

, et al. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J Manag Care Pharm 2010; 16: 703–712.

Yamabe

DiBonaventura

Pashos

. Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries. Clinicoecon Outcomes Res 2019; 11: 61–71.

Hatcher-Martin

Adams

Anderson

, et al. Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update. Neurology 2020; 94: 30–38.

Yeroushalmi

Maloni

Costello

, et al. Telemedicine and multiple sclerosis: A comprehensive literature review. J Telemed Telecare 2020; 26: 400–413.

Shaver

. The state of telehealth before and after the COVID-19 pandemic. Prim Care 2022; 49: 517–530.

Jacqueline

Maria

. Telemedicine use among adults: United States, 2021. Hyattsville, MD: National Center for Health Statistics, 2022.

10.

Lee

Grigorescu

Enogieru

, et al. Updated national survey trends in telehealth utilization and modality (2021-2022). Washington, DC: Office of the Assistant Secretary for Planning and Evaluation, 2023.

11.

Dixit

Ratwani

Bishop

, et al. The impact of expanded telehealth availability on primary care utilization. NPJ Digit Med 2022; 5: 141.

12.

Zachrison

Yan

Schwamm

. Changes in virtual and in-person health care utilization in a large health system during the COVID-19 pandemic. JAMA Netw Open 2021; 4: e2129973.

13.

Chen

Zhang

Gurley

, et al. Primary care utilization among telehealth users and non-users at a large urban public healthcare system. PLoS ONE 2022; 17: e0272605.

14.

Stamenova

Chu

Pang

, et al. Virtual care use during the COVID-19 pandemic and its impact on healthcare utilization in patients with chronic disease: A population-based repeated cross-sectional study. PLoS ONE 2022; 17: e0267218.

15.

Bove

Garcha

Bevan

, et al. Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions. Neurol Neuroimmunol Neuroinflamm 2018; 5: e505.

16.

Robb

Hyland

Goodman

. Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfaction. Mult Scler Relat Disord 2019; 36: 101258.

17.

Saadi

Himmelstein

Woolhandler

, et al. Racial disparities in neurologic health care access and utilization in the United States. Neurology 2017; 88: 2268–2275.

18.

Calocer

Dejardin

Kwiatkowski

, et al. Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients. Mult Scler Relat Disord 2020; 40: 101930.

19.

Abbatemarco Carlson

Ontaneda

, et al. Association of socioeconomic disadvantage and neighborhood disparities with clinical outcomes in multiple sclerosis patients. Mult Scler Relat Disord 2022; 61: 103734.

20.

Boorgu

DSSK

Venkatesh

Lakhani

, et al. The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. Mult Scler Relat Disord 2022; 65: 103994.

21.

Marrie

Cutter

Tyry

, et al. Does multiple sclerosis–associated disability differ between races? Neurology 2006; 66: 1235–1240.

22.

Pérez

Lincoln

. Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: A comparative study. Mult Scler Relat Disord 2021; 56: 103248.

23.

Hittle

Culpepper

Langer-Gould

, et al. Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region. JAMA Neurol 2023; 80: 693–701.

24.

Kind

AJH

Buckingham

. Making neighborhood-disadvantage metrics accessible—The Neighborhood Atlas. N Engl J Med 2018; 378: 2456–2458.

25.

Hatcher-Martin

Busis

Cohen

, et al. American Academy of Neurology telehealth position statement. Neurology 2021; 97: 334–339.

26.

Reed

Huang

Graetz

, et al. Treatment and follow-up care associated with patient-scheduled primary care telemedicine and in-person visits in a large integrated health system. JAMA Netw Open 2021; 4: e2132793.

27.

Zhou

Andes

Rolka

, et al. Changes in health care utilization among Medicare beneficiaries with diabetes 2 years into the COVID-19 pandemic. AJPM Focus 2023; 2: 100117.

28.

Adelman

Rane

Villa

. The cost burden of multiple sclerosis in the United States: A systematic review of the literature. J Med Econ 2013; 16: 639–647.

29.

Minden

Hoaglin

Hadden

, et al. Access to and utilization of neurologists by people with multiple sclerosis. Neurology 2008; 70: 1141–1149.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

Trends in direct healthcare utilization observed for persons with MS among teleneurology users and diverse populations